Target intelligence / Profile preview

Succinate dehydrogenase complex subunit C (SDHC)

Target
SDHC
Molecular classification
Enzyme, Mitochondrial respiratory chain component, Tricarboxylic acid cycle enzyme, Oxidoreductase
01

Overview

Succinate dehydrogenase complex subunit C is an integral membrane protein in the inner mitochondrial membrane, encoded by the SDHC gene. It anchors other succinate dehydrogenase (Complex II) subunits, facilitating electron transfer from succinate to ubiquinone as part of both the citric acid cycle and mitochondrial electron transport chain. SDHC plays a crucial role in oxidative energy production. Mutations in the SDHC gene disrupt this process, leading to cellular succinate accumulation, stabilization of hypoxia-inducible factors, and increased tumor risk, particularly paraganglioma and pheochromocytoma. While homologous proteins in fungi are targeted by SDH-inhibitor (SDHI) fungicides, the SDHC subunit is considered a tumor suppressor and essential enzyme in humans, not a direct therapeutic or pharmacologic target in clinical settings[1][3][4][5][8].

Other names
Succinate dehydrogenase cytochrome b560 subunit, mitochondrialSDHCSuccinate:ubiquinone oxidoreductase subunit CComplex II subunit C
02

Mechanism of action

Inhibition of SDHC/SDH impairs electron transport in mitochondria, leading to succinate accumulation and disruption of cellular respiration[5] Disease-causing mutations reduce SDH enzyme activity, promote hypoxia-inducible factor (HIF) stabilization, and drive tumorigenesis[1][3][4]

03

Biological functions

Electron transport in mitochondrial respirationConversion of succinate to fumarate in the citric acid (Krebs) cycleMitochondrial energy production (ATP synthesis)Tumor suppressionRegulation of hypoxia responses
04

Disease associations

Cancer (specifically, hereditary paraganglioma and pheochromocytoma)Paraganglioma-pheochromocytoma syndromeOther mitochondrial disorders
05

Safety considerations

Loss of SDHC/SDH function can cause metabolic dysfunction, tumor development, and is essential for cell viability[1][4]Inhibition in humans is not safe except in specific research contexts, due to the enzyme’s essential role in cellular energy metabolismIn agricultural use, resistance and nonspecific toxicity are concerns for SDHI fungicides targeting SdhC homologs in plants and fungi[5]
06

Interacting drugs

Succinate dehydrogenase inhibitors (SDHIs) used in antifungal applications[5]

1 more in the full profile.

07

Biomarkers

SDHC gene mutations or SDH deficiency as biomarkers for SDH-deficient tumors (e.g., paragangliomas and pheochromocytomas)[1][4]Succinate accumulation as a metabolic biomarker

Beyond the preview

Go deeper on Succinate dehydrogenase complex subunit C (SDHC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Succinate dehydrogenase complex subunit C (SDHC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call